Eversept Partners, LP Exagen Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.4 - $17.92 $1.3 Million - $1.87 Million	-104,437 Closed	0 $0
Q1 2021 Nov 08, 2023	BUY	$13.9 - $22.0 $317,392 - $502,348	22,834 Added 27.98%	104,437 $1.83 Million
Q1 2021 May 13, 2021	BUY	$13.9 - $22.0 $317,392 - $502,348	22,834 Added 27.98%	104,437 $1.83 Million
Q4 2020 Nov 08, 2023	BUY	$11.19 - $16.05 $913,137 - $1.31 Million	81,603 New	81,603 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$11.19 - $16.05 $913,137 - $1.31 Million	81,603 New	81,603 $1.08 Million

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.